Toronto, Ontario – December 18, 2024 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce Ventripoint and ASCEND Cardiovascular, a leading provider of cardiovascular IT solutions, have signed a term sheet defining the general terms and conditions for a non-exclusive license to Ventripoint’s VMS+ proprietary technology. The two parties expect to execute the license agreement within 30 days. ASCEND Cardiovascular has ov

In a landscape where healthcare IT is evolving at lightning speed, pediatric cardiology has been left behind, forced to make do with outdated, one-size-fits-all solutions. While the adult cardiovascular space has enjoyed the luxury of high-tech workflow solutions designed specifically for its unique needs, pediatric cardiology has struggled to catch up. It’s time to call it out: Pediatric cardiology is not a niche that should be relegated to the backseat when it comes to adva